NuCana plc [NASDAQ: NCNA] gained 17.62% or 0.8 points to close at $5.34 with a heavy trading volume of 3336033 shares. The company report on December 22, 2020 that NuCana Appoints Andrew Kay as Board Chairman.
Pharmaceutical Executive Brings a Wealth of Experience to NuCana’s Board of Directors.
Previously Served as CEO of Algeta, Chairman of Wilson Therapeutics and Chairman of KaNDy Therapeutics.
It opened the trading session at $4.55, the shares rose to $5.79 and dropped to $4.55, the range by which the price of stock traded the whole day. The daily chart for NCNA points out that the company has recorded 0.95% gains over the past six months. However, it is still -40.16% lower than its most recent low trading price.
If we look at the average trading volume of 168.58K shares, NCNA reached to a volume of 3336033 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about NuCana plc [NCNA]:
Truist have made an estimate for NuCana plc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 22, 2020. The new note on the price target was released on July 24, 2020, representing the official price target for NuCana plc stock. Previously, the target price had yet another raise to $20, while H.C. Wainwright analysts kept a Buy rating on NCNA stock.
The Average True Range (ATR) for NuCana plc is set at 0.30 The Price to Book ratio for the last quarter was 1.25, with the Price to Cash per share for the same quarter was set at 2.83.
Trading performance analysis for NCNA stock
NuCana plc [NCNA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 17.36. With this latest performance, NCNA shares gained by 13.62% in over the last four-week period, additionally plugging by 0.95% over the last 6 months – not to mention a rise of 1.91% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NCNA stock in for the last two-week period is set at 65.38, with the RSI for the last a single of trading hit 70.02, and the three-weeks RSI is set at 61.54 for NuCana plc [NCNA]. The present Moving Average for the last 50 days of trading for this stock 4.63, while it was recorded at 4.75 for the last single week of trading, and 5.31 for the last 200 days.
NuCana plc [NCNA]: A deeper dive into fundamental analysis
Return on Total Capital for NCNA is now -34.62, given the latest momentum, and Return on Invested Capital for the company is -28.94. Return on Equity for this stock declined to -29.05, with Return on Assets sitting at -26.76. When it comes to the capital structure of this company, NuCana plc [NCNA] has a Total Debt to Total Equity ratio set at 1.27. Additionally, NCNA Total Debt to Total Capital is recorded at 1.25, with Total Debt to Total Assets ending up at 1.15. Long-Term Debt to Equity for the company is recorded at 0.85, with the Long-Term Debt to Total Capital now at 0.84.
Reflecting on the efficiency of the workforce at the company, NuCana plc [NCNA] managed to generate an average of -$881,165 per employee.NuCana plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 12.50 and a Current Ratio set at 12.50.
NuCana plc [NCNA]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, NuCana plc posted -24/share EPS, while the average EPS was predicted by analysts to be reported at -16.2/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -48.10%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NCNA.
An analysis of insider ownership at NuCana plc [NCNA]
There are presently around $124 million, or 53.70% of NCNA stock, in the hands of institutional investors. The top three institutional holders of NCNA stocks are: SOFINNOVA INVESTMENTS, INC. with ownership of 5,599,999, which is approximately 20% of the company’s market cap and around 0.42% of the total institutional ownership; CAPITAL RESEARCH GLOBAL INVESTORS, holding 4,581,164 shares of the stock with an approximate value of $20.8 million in NCNA stocks shares; and CAPITAL INTERNATIONAL INVESTORS, currently with $20.05 million in NCNA stock with ownership of nearly 30.989% of the company’s market capitalization.
Positions in NuCana plc stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 23 institutional holders increased their position in NuCana plc [NASDAQ:NCNA] by around 12,177,784 shares. Additionally, 7 investors decreased positions by around 815,645 shares, while 5 investors held positions by with 14,322,939 shares. The mentioned changes placed institutional holdings at 27,316,368 shares, according to the latest SEC report filing. NCNA stock had 11 new institutional investments in for a total of 6,003,949 shares, while 6 institutional investors sold positions of 247,114 shares during the same period.